One may be a mutation or silencing of the von Hippel-Lindau (VHL) gene which is present in over 50 % of cases and is thought to lead in the accumulation of hypoxic-inducible factor 1-alpha (HIF1A), which then creates angiogenesis leading to further tumor growth and potential disease spread [7]. This evidence concerns the gene HIF1A and neoplasm.